RespiCell<sup>TM</sup>: An Innovative Dissolution Apparatus for Inhaled Products
To overcome some of the shortfalls of the types of dissolution testing currently used for pulmonary products, a new custom-built dissolution apparatus has been developed. For inhalation products, the main in vitro characterisation required by pharmacopoeias is the deposition of the active pharmaceut...
Main Authors: | Fabio Sonvico, Veronica Chierici, Giada Varacca, Eride Quarta, Davide D’Angelo, Ben Forbes, Francesca Buttini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/10/1541 |
Similar Items
-
Understanding the Importance of Capsules in Dry Powder Inhalers
by: Francesca Buttini, et al.
Published: (2021-11-01) -
Optimization of the Transwell<sup>®</sup> System for Assessing the Dissolution Behavior of Orally Inhaled Drug Products through In Vitro and In Silico Approaches
by: Elham Amini, et al.
Published: (2021-07-01) -
Dissolution and Absorption of Inhaled Drug Particles in the Lungs
by: Basanth Babu Eedara, et al.
Published: (2022-11-01) -
Identifying Biomarkers for Accurate Detection of Stress
by: Kiran Jambhale, et al.
Published: (2022-11-01) -
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
by: Davide D’Angelo, et al.
Published: (2023-03-01)